02.04.11
Green Planet Bioengineering, a subsidiary of ONE Bio, Corp., Miami, FL, has signed a U.S. distribution agreement with P&G Ingredient, LLC, a producer and distributor of botanical and chemical extracts.
The agreement includes pre-orders for the company's raw extracts, including resveratrol, stevia leaf powder, 5-HTP, polygonum extract and spirulina powder. Headquartered in New Jersey and operating for more than a decade, P&G is a producer in the botanical and chemical extracts field, with product distribution that ranges from raw botanicals and chemical ingredients to API (Active Pharmaceutical Ingredients) and ANI (Active Natural Ingredients).
"This agreement is an important part of our strategy to expand distribution of our highly sought-after raw chemicals and herbal extracts in the United States," stated ONE's CEO, Marius Silvasan. "Our sales strategy for 2011 is focused on expanding our distribution in three key markets: the U.S., China and Japan. The New Jersey/New York region is a strategic entry point in the U.S., as it has the largest concentration of botanical extract and ingredient distributors in the nation. New Jersey is also home to five foreign-trade zones that allow companies involved in international trade to cut, delay or eliminate customs charges, which will increase the competitiveness of our products."
Mr. Silvasan continued, "In our aging society, a growing number of American consumers are seeking to maintain a healthy lifestyle focused on alternative medicines and preventative care. These key factors will continue to drive increased sales of nutraceutical and health-related products, including organic food products."
The agreement includes pre-orders for the company's raw extracts, including resveratrol, stevia leaf powder, 5-HTP, polygonum extract and spirulina powder. Headquartered in New Jersey and operating for more than a decade, P&G is a producer in the botanical and chemical extracts field, with product distribution that ranges from raw botanicals and chemical ingredients to API (Active Pharmaceutical Ingredients) and ANI (Active Natural Ingredients).
"This agreement is an important part of our strategy to expand distribution of our highly sought-after raw chemicals and herbal extracts in the United States," stated ONE's CEO, Marius Silvasan. "Our sales strategy for 2011 is focused on expanding our distribution in three key markets: the U.S., China and Japan. The New Jersey/New York region is a strategic entry point in the U.S., as it has the largest concentration of botanical extract and ingredient distributors in the nation. New Jersey is also home to five foreign-trade zones that allow companies involved in international trade to cut, delay or eliminate customs charges, which will increase the competitiveness of our products."
Mr. Silvasan continued, "In our aging society, a growing number of American consumers are seeking to maintain a healthy lifestyle focused on alternative medicines and preventative care. These key factors will continue to drive increased sales of nutraceutical and health-related products, including organic food products."